Category: Finance
-
CEPI Funds New Broad Coronavirus Vaccine
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells.
-
Infographic – Biotech Index Continues Decline in Q2
A new look at the Nasdaq Biotechnology Index shows investors’ chill in biotech stocks begun earlier in the year continued into the second quarter of 2022.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
Infographic – Q1 Mental Health Tech Funds Drop
After a year of nearly constant gains in 2021, venture investments in digital mental health companies took a sharp drop in the first quarter of 2022.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.
-
Life Science Investors Raise $1.1B for New Fund
A venture capital company specializing in health and life sciences start-up enterprises is raising $1.1 billion for a new investment fund.
-
Companies Partner on Optimal Parkinson’s Drug Delivery
Two companies are developing a system to identify optimal times for people with Parkinson’s disease to take their symptom-reducing medications.
-
Challenge Seeks Tech, Models to Reduce Stillbirths
A research competition is seeking better technologies to measure gestational development and predict outcomes to reduce the number of stillbirths by half.
-
GSK Acquires Advanced Vaccine Biotech in $3.3B Deal
Drug maker GSK is buying a biotechnology company developing vaccines for respiratory and infectious diseases that generate multiple immune responses.